PIC Therapeutics Appointed Richard Gedrich, PhD as Chief Development Officer
28 Sep 2023 //
BUSINESSWIRE
PIC Therapeutics Presents Pre-Clinical Data on eIF4E Regulators at AACR 2023
17 Apr 2023 //
BUSINESSWIRE
28 Sep 2023 //
BUSINESSWIRE
17 Apr 2023 //
BUSINESSWIRE